Fisetin to Reduce Senescence and Mobility Impairment in PAD

NCT06399809 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

34

Enrollment

OTHER

Sponsor class

Conditions

Peripheral Arterial Disease
Aging
Peripheral Vascular Diseases
Walking, Difficulty
Claudication

Interventions

DRUG: Fisetin
DRUG: Placebo

Sponsor

Northwestern University